Lipkowitz et al. reported that APOL1 risk variants were significantly associated with CKD and kidney disease progression in African-American participants of the African American Study of Kidney Disease and Hypertension (AASK) trial (23). The gene discussed is APOL1; the disease is kidney disorder.